logo-loader
NASDAQ:ONVO

Organovo Holdings Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$35.67 m
Price
$0.27
Change
-0.44%
52 weeks high
1.27
52 weeks low
0.22

Filter by article type

Viewing results 1-4 of 4

Health

Organovo tumbles after fiscal 4Q revenue miss, extended timeline for liver tissue program

CEO Taylor J Crouch says preclinical development of 3D-bioprinted tissues will extend into calendar 2020...

on 05/23/2019
Health

Organovo expects FDA meeting in 2019 on 3D-bioprinted tissues for liver disease treatment

The biotech estimates that it has sufficient funds to meet operating and capital requirements through fiscal 2020...

on 02/08/2019
Health

Organovo reports smaller loss and sharp fall in revenue

The net loss for the quarter was lower compared to last year but revenues slid...

on 08/09/2018
Health

Shares of Organovo fall after it narrows fiscal 2018 guidance

The San Diego company, which develops 3D human tissue models, also missed fiscal 3Q revenue estimates...

on 05/31/2018